PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1485955

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1485955

Dengue Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

PUBLISHED: May 22, 2024

PAGES: 240 Pages

DELIVERY TIME: 2-5 business days

ADD TO COMPARE

SELECT AN OPTION

Description

The global incidence of dengue has been increasing rapidly, with significant impacts across major regions including Africa, the Americas, the Eastern Mediterranean, Southeast Asia, and the Western Pacific. The World Health Organization (WHO) reports a continuous rise in dengue cases, highlighting the urgent need for effective diagnostic solutions.

Rising Dengue Cases Across the Globe

Americas

In the Americas, the prevalence of dengue has reached alarming levels, with millions of reported cases. Brazil has emerged as a hotspot, contributing a substantial portion of these cases. The surge in dengue cases in Brazil underscores the growing health crisis, with a significant increase compared to previous figures.

Western Pacific Region

The Western Pacific region has also witnessed a significant number of suspected dengue cases. The Philippines and Malaysia are among the most affected countries, both reporting high case numbers. This escalating prevalence of the dengue virus in these regions is driving the demand for diagnostic kits, crucial for timely and accurate detection.

Climate Change and Dengue Fever

Impact of Climate Change

Climate change is exacerbating the prevalence of dengue fever worldwide. Recent outbreaks of dengue, chikungunya, and West Nile virus in previously unaffected countries highlight the potential threats posed by global warming. Changes in climate have heightened current and future risks in various regions, including Europe, significantly impacting vector distribution and potential disease transmission.

Environmental Factors

Environmental factors such as high rainfall and humidity create favorable breeding conditions for mosquitoes. Additionally, curtailed water supply and disrupted sanitation services facilitate mosquito proliferation, while warm temperatures extend the active season for these vectors. These climatic changes are likely to increase the burden of dengue fever, subsequently driving the growth of the dengue testing market.

Innovations in Dengue Testing

Need for Cost-Effective Diagnostic Kits

Currently, the available diagnostic test kits for dengue are less effective, creating a need for cost-effective kits with high specificity and sensitivity. The high price and limited effectiveness of existing test kits have prompted companies to focus on developing reliable and affordable diagnostic methods. Increasing research and development activities aim to produce highly specific and sensitive diagnostic kits, opening new growth opportunities for manufacturers.

Development of Point-of-Care Tests

Manufacturers are prioritizing the development of point-of-care tests that are rapid, sensitive, and easy to use. Many existing methods for detecting the dengue virus rely on cell culture and mice inoculation, which are slow and expensive. There is a pressing need for rapid, user-friendly, and sensitive detection methods to enhance the efficiency of dengue diagnosis.

Global Dengue Testing Market by Region

Dominance of Asia Pacific

The Asia Pacific region has been at the forefront of the global dengue testing market in terms of revenue. This trend is expected to continue, with Asia Pacific projected to remain the most attractive market for dengue testing. The region's significant share in the global dengue testing market underscores its critical role in addressing the dengue epidemic.

Key Market Players Include:

Abnova Corporation
Roche Molecular Systems Inc.
Abbott Laboratories
InBios International, Inc.
NovaTec Immundiagnostica GmbH
Euroimmun AG (Sub. PerkinElmer)
Quest Diagnostics
Certest Biotec S.L.
OriGene Technologies
Thermo Fisher Scientific Inc.
Others.

Global Dengue Testing Market Segmentation:

By Product Type:

Premium
Mid
Low

By End User:

Hospitals
Public Health Laboratory
Diagnostic Centers
Others

By Region:

China
India
Japan
Indonesia
South Korea
Rest of Asia Pacific

1. Executive Summary

1.1. Global Dengue Testing Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Economic Overview
- 2.6.1. World Economic Projections
2.7. PESTLE Analysis

3. Global Dengue Testing Market Outlook, 2018 - 2031

3.1. Global Dengue Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. ELISA-based Tests
  - 3.1.1.2. RT-PCR based Tests
  - 3.1.1.3. Dengue IgG/IgM Rapid Test
3.2. Global Dengue Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Hospitals
  - 3.2.1.2. Public Health Laboratory
  - 3.2.1.3. Diagnostic Centers
  - 3.2.1.4. Others
3.3. Global Dengue Testing Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. North America
  - 3.3.1.2. Europe
  - 3.3.1.3. Asia Pacific
  - 3.3.1.4. Latin America
  - 3.3.1.5. Middle East & Africa

4. North America Dengue Testing Market Outlook, 2018 - 2031

4.1. North America Dengue Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. ELISA-based Tests
  - 4.1.1.2. RT-PCR based Tests
  - 4.1.1.3. Dengue IgG/IgM Rapid Test
4.2. North America Dengue Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Hospitals
  - 4.2.1.2. Public Health Laboratory
  - 4.2.1.3. Diagnostic Centers
  - 4.2.1.4. Others
4.3. North America Dengue Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. U.S. Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 4.3.1.2. U.S. Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 4.3.1.3. Canada Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 4.3.1.4. Canada Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
- 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Dengue Testing Market Outlook, 2018 - 2031

5.1. Europe Dengue Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. ELISA-based Tests
  - 5.1.1.2. RT-PCR based Tests
  - 5.1.1.3. Dengue IgG/IgM Rapid Test
5.2. Europe Dengue Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Hospitals
  - 5.2.1.2. Public Health Laboratory
  - 5.2.1.3. Diagnostic Centers
  - 5.2.1.4. Others
5.3. Europe Dengue Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Germany Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.2. Germany Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.3. U.K. Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.4. U.K. Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.5. France Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.6. France Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.7. Italy Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.8. Italy Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.9. Turkey Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.10. Turkey Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.11. Russia Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.12. Russia Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.13. Rest of Europe Dengue Testing Market by Product Type, Value (US$Bn), 2018 - 2031
  - 5.3.1.14. Rest of Europe Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
- 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Dengue Testing Market Outlook, 2018 - 2031

6.1. Asia Pacific Dengue Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. ELISA-based Tests
  - 6.1.1.2. RT-PCR based Tests
  - 6.1.1.3. Dengue IgG/IgM Rapid Test
6.2. Asia Pacific Dengue Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Hospitals
  - 6.2.1.2. Public Health Laboratory
  - 6.2.1.3. Diagnostic Centers
  - 6.2.1.4. Others
- 6.2.2. BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific Dengue Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. China Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.3.1.2. China Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.3. Japan Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.3.1.4. Japan Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.5. South Korea Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.3.1.6. South Korea Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.7. India Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.3.1.8. India Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.9. Southeast Asia Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.3.1.10. Southeast Asia Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.11. Rest of Asia Pacific Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.3.1.12. Rest of Asia Pacific Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
- 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Dengue Testing Market Outlook, 2018 - 2031

7.1. Latin America Dengue Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. ELISA-based Tests
  - 7.1.1.2. RT-PCR based Tests
  - 7.1.1.3. Dengue IgG/IgM Rapid Test
7.2. Latin America Dengue Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America Dengue Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Brazil Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 7.3.1.2. Brazil Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.3.1.3. Mexico Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 7.3.1.4. Mexico Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.3.1.5. Argentina Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 7.3.1.6. Argentina Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.3.1.7. Rest of Latin America Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 7.3.1.8. Rest of Latin America Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
- 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Dengue Testing Market Outlook, 2018 - 2031

8.1. Middle East & Africa Dengue Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. ELISA-based Tests
  - 8.1.1.2. RT-PCR based Tests
  - 8.1.1.3. Dengue IgG/IgM Rapid Test
8.2. Middle East & Africa Dengue Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Hospitals
  - 8.2.1.2. Public Health Laboratory
  - 8.2.1.3. Diagnostic Centers
  - 8.2.1.4. Others
- 8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Middle East & Africa Dengue Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. GCC Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 8.3.1.2. GCC Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.3.1.3. South Africa Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 8.3.1.4. South Africa Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.3.1.5. Egypt Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 8.3.1.6. Egypt Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.3.1.7. Nigeria Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 8.3.1.8. Nigeria Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.3.1.9. Rest of Middle East & Africa Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 8.3.1.10. Rest of Middle East & Africa Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
- 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. By Product vs by End User Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
- 9.4.1. Thermo Fisher Scientific Inc.
  - 9.4.1.1. Company Overview
  - 9.4.1.2. Therapy Portfolio
  - 9.4.1.3. Financial Overview
  - 9.4.1.4. Business Strategies and Development
- 9.4.2. Roche Molecular Systems Inc.
  - 9.4.2.1. Company Overview
  - 9.4.2.2. Therapy Portfolio
  - 9.4.2.3. Financial Overview
  - 9.4.2.4. Business Strategies and Development
- 9.4.3. Abbott Laboratories
  - 9.4.3.1. Company Overview
  - 9.4.3.2. Therapy Portfolio
  - 9.4.3.3. Financial Overview
  - 9.4.3.4. Business Strategies and Development
- 9.4.4. InBios International, Inc.
  - 9.4.4.1. Company Overview
  - 9.4.4.2. Therapy Portfolio
  - 9.4.4.3. Financial Overview
  - 9.4.4.4. Business Strategies and Development
- 9.4.5. NovaTec Immundiagnostica GmbH
  - 9.4.5.1. Company Overview
  - 9.4.5.2. Therapy Portfolio
  - 9.4.5.3. Financial Overview
  - 9.4.5.4. Business Strategies and Development
- 9.4.6. Quest Diagnostics
  - 9.4.6.1. Company Overview
  - 9.4.6.2. Therapy Portfolio
  - 9.4.6.3. Financial Overview
  - 9.4.6.4. Business Strategies and Development
- 9.4.7. Certest Biotec S.L.
  - 9.4.7.1. Company Overview
  - 9.4.7.2. Therapy Portfolio
  - 9.4.7.3. Financial Overview
  - 9.4.7.4. Business Strategies and Development
- 9.4.8. OriGene Technologies
  - 9.4.8.1. Company Overview
  - 9.4.8.2. Therapy Portfolio
  - 9.4.8.3. Financial Overview
  - 9.4.8.4. Business Strategies and Development
- 9.4.9. Abnova Corporation
  - 9.4.9.1. Company Overview
  - 9.4.9.2. Therapy Portfolio
  - 9.4.9.3. Financial Overview
  - 9.4.9.4. Business Strategies and Development
- 9.4.10. Others
  - 9.4.10.1. Company Overview
  - 9.4.10.2. Therapy Portfolio
  - 9.4.10.3. Financial Overview
  - 9.4.10.4. Business Strategies and Development

10. Appendix

10.1.Research Methodology
10.2.Report Assumptions
10.3.Acronyms and Abbreviations

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ